Pharmacomechanical Thrombectomy Market Size, Share, Opportunities, And Trends By Product Type (Pharmacomechanical Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices), By Application (Cardiovascular, Neurovascular, Peripheral Vascular), By Technology (Automated Devices, Manual Devices), By End-User (Hospitals, Ambulatory Surgical Centers, Others), And By Geography - Forecasts From 2025 To 2030
- Published : Jan 2025
- Report Code : KSI061617265
- Pages : 142
Pharmacomechanical Thrombectomy Market Size
The Pharmacomechanical Thrombectomy Market is set to witness robust growth at a CAGR of 7.24% during the forecast period to be worth US$ 2.461 billion in 2030 from US$ 1.735 billion in 2025.
Pharmacomechanical Thrombectomy Market Trends
The pharmacomechanical thrombectomy is the process or technique, through which the thrombus burden is diminished, using mechanical therapies and low-dose fibrinolysis. The global pharmacomechanical thrombectomy market is expected to witness major growth in the global market majorly with the increasing global cases of thromboembolic diseases and shifting preference towards minimally invasive procedures. Similarly, the advancement in healthcare and medical technology is also expected to propel the growth of the global market, as with the increasing development in the sector, the efficacy and effectiveness of pharmacomechanical thrombectomy therapy are expected to rise.
Pharmacomechanical Thrombectomy Market Growth Factors:
- The Pharmacomechanical Thrombectomy Market is witnessing a significant growth driven by two major factors
Increasing global prevalence of Thromboembolic diseases: The major factor propelling the growth of the global pharmacomechanical thrombectomy market is the increasing global prevalence of thromboembolic diseases, which includes ischemic strokes and deep vein thrombosis. The Center for Disease Control and Prevention of the USA stated that in the nation, the annual cases of venous thromboembolism were recorded at about 900,000 annually.
Shifting preference towards minimally invasive procedures: The growing preferences for minimally invasive procedures are also expected to propel the growth of the market during the estimated timeline. The pharmacomechanical thrombectomy therapy system offers minimally invasive surgeries, which results in faster recovery of the patients.
Pharmacomechanical Thrombectomy Market Segmentation Analysis by Product Type
- Pharmacomechanical Devices: The pharmacomechanical devices category under the application segment is expected to grow at a greater rate, compared to other types of devices in the market. The pharmacomechanical devices combine the thrombolytic agents with mechanical thrombectomy, which enhances the dissolution of clots.
- Mechanical Thrombectomy Devices: The mechanical thrombectomy devices category is also expected to grow at a higher rate during the forecasted timeline. The mechanical thrombectomy devices feature devices, like stent retrievers and aspiration catheters, which physically remove clots.
- Ultrasonic Thrombectomy Devices: The ultrasonic thrombectomy devices use the technology of ultrasound to dissolve clots, that can further be removed.
Pharmacomechanical Thrombectomy Market Segmentation Analysis by Application
- Cardiovascular: The cardiovascular thrombectomy is a type of cardiac surgery, which helps in removing the blood clots which are trapped in the veins and arteries of the body. In cardiovascular applications, the thrombectomy helps in the therapy for myocardial infection and peripheral artery diseases.
- Neurovascular: The neurology thrombectomy procedure commonly helps in the treatment of ischemic strokes, in which the clots from cerebral arteries are removed.
- Peripheral Vascular: Peripheral vascular thrombectomy is a type of surgical treatment, which helps in removing blood clots from the peripheral arteries.
Pharmacomechanical Thrombectomy Market Segmentation Analysis by Technology
- Automated Devices: Under the technology segment of the pharmacomechanical thrombectomy market, the automated device category is expected to attain a greater market share. The automated device for thrombectomy offers enhanced performance with increased precision in clot removal.
- Manual Devices: The manual device category in the application segment is also expected to grow at a higher rate during the forecasted timeline. The manual devices for thrombectomy require the precision of the operator for the removal of clots.
Pharmacomechanical Thrombectomy Market Segmentation Analysis by End-User
- Hospitals: The hospital category in the end-user segment of the global pharmacomechanical thrombectomy market is expected to grow at a greater rate. The hospitals are among the major operators of the thrombectomy systems, as with the availability of advanced treatment options, and wide area utilization of the system.
- Ambulatory Surgical Centers: The share of ambulatory surgical centers in the pharmacomechanical thrombectomy market is also expected to grow significantly, as these centers offer specialized outpatient surgical procedures.
- Others (research institute and rehabilitation center): The share of another category in the pharmacomechanical thrombectomy market is expected to attain a slower growth rate during the forecasted timeline. The thrombectomy devices offer limited application across research institutes and rehabilitation centers.
Pharmacomechanical Thrombectomy Market Geographical Outlook:
The pharmacomechanical thrombectomy market report analyzes growth factors across the following five regions:
- North America: The North American region is expected to attain a greater market share in the global pharmacomechanical thrombectomy market, majorly with the increasing adoption of advanced medical technology and increasing consumer preference towards minimally invasive procedures. The increasing cases of thromboembolic diseases in the region also witness significant growth, propelling the demand for the market.
- Europe: The major factor propelling the growth of the pharmacomechanical thrombectomy market in the European region is the increasing advancement in medical technology in the region. With the introduction of favorable governmental policies in the healthcare sector, the market is further expected to grow.
- Asia Pacific: The Asia Pacific region is among the fastest emerging regions in the healthcare sector, which is expected to grow at a greater rate in the global pharmacomechanical thrombectomy market during the forecasted timeline. The increasing investment and introduction of governmental policies to boost the healthcare sector are among the key factors boosting the growth of the market.
- South America & MEA: Increasing innovations and development in the healthcare sector are among the key factors driving the growth of the global pharmacomechanical thrombectomy market in the South American region and the Middle East & African region.
Pharmacomechanical Thrombectomy Market – Competitive Landscape
- Boston Scientific Corporation: With the AngioJet system, which combines active aspiration and Power PulseTM technology to efficiently treat a variety of thrombosed arteries, the company leads the pharmacomechanical thrombectomy market.
- Abbott: The company concentrates on creating cutting-edge thrombectomy solutions, using its knowledge of vascular interventions to improve patient outcomes using cutting-edge technologies and minimally invasive clot removal techniques.
- Medtronic plc: One of the biggest players in the thrombectomy market, with devices for fast clot removal and restoration of blood flow, while keeping patient safety and effectiveness at the forefront of vascular procedures.
- Inari Medical, Inc: Specializes in advanced thrombectomy devices that employ a novel technique to remove blood clots, focusing on improving patient outcomes while reducing the risks associated with conventional procedures.
These companies are the leaders in the development and production of pharmacomechanical thrombectomy systems and also contribute extensively to innovation and development in the healthcare sector.
Pharmacomechanical Thrombectomy Market Latest Developments
- In September 2024, Vesalio Inc., an American-based medical device leader, announced the launch of pVasc Thrombectomy system, for peripheral occlusion in the US market. The system features the non-surgical removing capability of peripheral occasions.
Pharmacomechanical Thrombectomy Market Scope:
Report Metric | Details |
Pharmacomechanical Thrombectomy Market Size in 2025 | US$1.735 billion |
Pharmacomechanical Thrombectomy Market Size in 2030 | US$2.461 billion |
Growth Rate | CAGR of 7.24% |
Study Period | 2020 to 2030 |
Historical Data | 2020 to 2023 |
Base Year | 2024 |
Forecast Period | 2025 – 2030 |
Forecast Unit (Value) | USD Billion |
Segmentation |
|
Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
List of Major Companies in the Pharmacomechanical Thrombectomy Market |
|
Customization Scope | Free report customization with purchase |
Pharmacomechanical Thrombectomy Market is analyzed into the following segments:
- By Product Type
- Pharmacomechanical Devices
- Mechanical Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
- By Application
- Cardiovascular
- Neurovascular
- Peripheral Vascular
- By Technology
- Automated Devices
- Manual Devices
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Geography
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Frequently Asked Questions (FAQs)
The pharmacomechanical thrombectomy market is expected to reach a total market size of US$2.461 billion by 2030.
Pharmacomechanical Thrombectomy Market is valued at US$1.735 billion in 2025.
The global pharmacomechanical thrombectomy market is expected to grow at a CAGR of 7.24% during the forecast period.
Advancements in technology, increasing stroke incidence, and growing awareness of thrombectomy benefits are key drivers for market growth.
The North America region is anticipated to hold a significant share of the pharmacomechanical thrombectomy market.
1. EXECUTIVE SUMMARY
- Market Overview
- Key Trends and Insights
- Market Size and Forecast
2. INTRODUCTION
- Definition and Scope
- Growing urbanization
- Importance of sustainability
3. MARKET DYNAMICS
- Drivers of Market Growth
- Challenges and Barriers
- Opportunities in Emerging Markets
- Regulatory and Environmental Factors
4. SEGMENTATION ANALYSIS
- By Product Type
- Pharmacomechanical Devices
- Mechanical Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
- By Application
- Cardiovascular
- Neurovascular
- Peripheral Vascular
- By Technology
- Automated Devices
- Manual Devices
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
5. COMPETITIVE LANDSCAPE
- Key Market Players
- Company Profiles and Strategies
- Market Share Analysis
6. MARKET TRENDS AND INNOVATIONS
- Increasing global prevalence of Thromboembolic diseases.
- Shifting preference towards minimally invasive procedures.
- Advancement in healthcare and medical technology.
- Increasing investment in the healthcare sector.
7. MARKET OUTLOOK AND FORECAST
- Market Size and Growth Projections (2023–2030)
- Regional Market Outlook
8. REGULATORY FRAMEWORK
- Intellectual Property Rights
- Data Privacy and Security
9. CASE STUDIES AND INDUSTRY APPLICATIONS
- Automated and manual devices
- Cardiovascular and neurological application
- Ultrasonic and mechanical thrombectomy devices
10. CONCLUSION AND RECOMMENDATIONS
- Key Takeaways
- Strategic Recommendations for Stakeholders
11. APPENDICES
- Research Methodology
- Data Sources and References
- Glossary of Terms
Boston Scientific Corporation
Abbott
Medtronic plc
Inari Medical, Inc
Terumo
BD
Related Reports
Report Name | Published Month | Download Sample |
---|---|---|
Neurovascular Devices Market: Size, Share, Trends, Forecast 2030 | Dec 2024 | |
Smart Medical Device Market Forecast 2023-2028 | Free Sample | Dec 2023 | |
Surgical Equipment Market Size & Forecast 2028 | Free Sample | Oct 2023 | |
Peripheral Vascular Intervention Market Insights: Forecast 2030 | Jan 2025 |